Coya Therapeutics Analyst Ratings
Coya Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/17/2023 | 166.34% | Chardan Capital | $11 → $11 | Reiterates | Buy → Buy |
| 06/08/2023 | 166.34% | Chardan Capital | $9 → $11 | Maintains | Buy |
| 06/07/2023 | 577.97% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/18/2023 | 263.2% | BTIG | → $15 | Initiates Coverage On | → Buy |
| 05/17/2023 | 117.92% | Chardan Capital | → $9 | Reiterates | Buy → Buy |
| 05/16/2023 | 577.97% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/10/2023 | 577.97% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/03/2023 | 577.97% | EF Hutton | → $28 | Initiates Coverage On | → Buy |
| 03/30/2023 | 117.92% | Chardan Capital | → $9 | Reiterates | → Buy |
| 03/22/2023 | 117.92% | Chardan Capital | → $9 | Reiterates | → Buy |
| 01/26/2023 | 117.92% | Chardan Capital | → $9 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 07/17/2023 | 166.34% | 查丹资本 | 11 美元 → 11 美元 | 重申 | 购买 → 购买 |
| 06/08/2023 | 166.34% | 查丹资本 | 9 美元 → 11 美元 | 维护 | 买 |
| 06/07/2023 | 577.97% | EF Hutton | → 28 美元 | 重申 | 购买 → 购买 |
| 05/18/2023 | 263.2% | BTIG | → 15 美元 | 开启覆盖范围 | → 购买 |
| 05/17/2023 | 117.92% | 查丹资本 | → 9 美元 | 重申 | 购买 → 购买 |
| 05/16/2023 | 577.97% | EF Hutton | → 28 美元 | 重申 | 购买 → 购买 |
| 05/10/2023 | 577.97% | EF Hutton | → 28 美元 | 重申 | 购买 → 购买 |
| 05/03/2023 | 577.97% | EF Hutton | → 28 美元 | 开启覆盖范围 | → 购买 |
| 03/30/2023 | 117.92% | 查丹资本 | → 9 美元 | 重申 | → 购买 |
| 03/22/2023 | 117.92% | 查丹资本 | → 9 美元 | 重申 | → 购买 |
| 01/26/2023 | 117.92% | 查丹资本 | → 9 美元 | 开启覆盖范围 | → 购买 |
What is the target price for Coya Therapeutics (COYA)?
Coya Therapeutics（COYA）的目标价格是多少？
The latest price target for Coya Therapeutics (NASDAQ: COYA) was reported by Chardan Capital on July 17, 2023. The analyst firm set a price target for $11.00 expecting COYA to rise to within 12 months (a possible 166.34% upside). 11 analyst firms have reported ratings in the last year.
Chardan Capital于2023年7月17日公布了Coya Therapeutics（纳斯达克股票代码：COYA）的最新目标股价。这家分析公司将目标股价定为11.00美元，预计COYA将在12个月内升至12个月内（可能上涨166.34％）。去年有11家分析公司公布了评级。
What is the most recent analyst rating for Coya Therapeutics (COYA)?
分析师对Coya Therapeutics（COYA）的最新评级是多少？
The latest analyst rating for Coya Therapeutics (NASDAQ: COYA) was provided by Chardan Capital, and Coya Therapeutics reiterated their buy rating.
Coya Therapeutics（纳斯达克股票代码：COYA）的最新分析师评级由Chardan Capital提供，Coya Therapeutics重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Coya Therapeutics (COYA)?
Coya Therapeutics（COYA）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coya Therapeutics was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Coya Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Coya Therapeutics的最后一次评级是在2023年7月17日提交的，因此你应该预计下一个评级将在2024年7月17日左右公布。
Is the Analyst Rating Coya Therapeutics (COYA) correct?
分析师对 Coya Therapeutics (COYA) 的评级正确吗？
While ratings are subjective and will change, the latest Coya Therapeutics (COYA) rating was a reiterated with a price target of $11.00 to $11.00. The current price Coya Therapeutics (COYA) is trading at is $4.13, which is out of the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Coya Therapeutics（COYA）评级得到了重申，目标股价为11.00美元至11.00美元。Coya Therapeutics（COYA）目前的交易价格为4.13美元，超出了分析师的预测区间。